ArticleDiscover oncology2025

Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma.

Qianqian Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.